SCYNEXIS, Inc. (SCYX) NASDAQ

Currency In USD

AD

SCYNEXIS, Inc.

Address

1 Evertrust Plaza

Jersey City, NJ 07302-6548

United States of America (the)

Phone

201 884 5485

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

18

First IPO Date

May 02, 2014

Key Executives

NameTitlePayYear Born
David Gonzalez AnguloChief Executive Officer, President & Director948,9111965
Scott SukenickChief Legal Officer & Corporate Secretary642,6671978
Ivor MacleodExecutive Officer651,1231961
Sanjay S. SubramanianChief Financial Officer651,1231976
Rossana Ferrara-PontorieroSenior Vice President of Business Development & Portfolio Management0N/A
Todd MingaSenior Vice President of Research & Development0N/A
Daniella GiganteVice President of Human Resources & Information Technology0N/A
AD

Description

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.

AD